EMEA-002081-PIP01-16
Key facts
Active substance |
|
Therapeutic area |
Cardiovascular diseases
|
Decision number |
P/0125/2017
|
PIP number |
EMEA-002081-PIP01-16
|
Pharmaceutical form(s) |
Modified-release tablet
|
Condition(s) / indication(s) |
Treatment of hypertension
|
Route(s) of administration |
Oral use
|
Contact for public enquiries |
Pharmaceutical Works Polpharma SA
|
Decision type |
W: decision granting a waiver in all age groups for all conditions or indications
|